Article Details
Retrieved on: 2025-01-09 17:31:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Eurofins' contribution to biopharma by providing assays for obesity drug discovery targeting peptide hormones like GLP-1. It links the concept of biopharma with obesity treatments and mentions related companies and platforms.
Article found on: www.drugtargetreview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here